Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Marco Del Chiaro

Concepts (599)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
182
2026
928
33.990
 Why?
Pancreatectomy
84
2026
289
19.910
 Why?
Carcinoma, Pancreatic Ductal
72
2026
293
17.690
 Why?
Adenocarcinoma
33
2026
925
6.930
 Why?
Pancreaticoduodenectomy
35
2026
137
6.900
 Why?
Neoadjuvant Therapy
33
2026
465
6.840
 Why?
Adenocarcinoma, Mucinous
18
2025
76
5.230
 Why?
Mesenteric Veins
10
2025
24
4.780
 Why?
Pancreas
41
2026
341
4.200
 Why?
Portal Vein
15
2026
117
4.060
 Why?
Carcinoma, Papillary
11
2025
77
2.960
 Why?
Pancreatic Cyst
12
2025
50
2.800
 Why?
Antineoplastic Combined Chemotherapy Protocols
19
2026
1963
2.600
 Why?
Ampulla of Vater
8
2026
40
2.210
 Why?
Common Bile Duct Neoplasms
7
2026
28
2.180
 Why?
Pancreatic Fistula
11
2023
35
2.100
 Why?
Retrospective Studies
100
2026
17291
2.040
 Why?
Postoperative Complications
35
2026
2970
1.970
 Why?
Aged
101
2026
26153
1.940
 Why?
Humans
261
2026
145474
1.900
 Why?
CA-19-9 Antigen
5
2026
34
1.870
 Why?
Survival Rate
26
2026
2090
1.780
 Why?
Pancreatic Ducts
10
2022
82
1.730
 Why?
Middle Aged
109
2026
36215
1.660
 Why?
Prognosis
33
2026
4316
1.640
 Why?
Neoplasm Recurrence, Local
8
2026
1149
1.540
 Why?
Exocrine Pancreatic Insufficiency
5
2019
24
1.510
 Why?
Mesenteric Artery, Superior
5
2026
28
1.460
 Why?
Chemotherapy, Adjuvant
17
2026
423
1.440
 Why?
Vascular Surgical Procedures
5
2025
343
1.390
 Why?
Gastrointestinal Neoplasms
2
2023
73
1.330
 Why?
Early Detection of Cancer
6
2021
485
1.320
 Why?
Male
125
2026
72842
1.320
 Why?
Aged, 80 and over
46
2025
8333
1.310
 Why?
Pancreas Transplantation
24
2010
71
1.240
 Why?
Female
122
2026
78844
1.210
 Why?
Treatment Outcome
43
2026
11772
1.090
 Why?
Pancreatitis, Chronic
6
2020
64
1.080
 Why?
Neoplasms, Cystic, Mucinous, and Serous
4
2025
27
1.030
 Why?
Neoplasm Staging
15
2025
1471
1.010
 Why?
Databases, Factual
4
2025
1490
0.990
 Why?
Adult
77
2026
40777
0.950
 Why?
Quality of Life
8
2025
3204
0.940
 Why?
Anastomotic Leak
2
2025
45
0.940
 Why?
Neoplasm Invasiveness
10
2026
506
0.930
 Why?
Chyle
1
2025
4
0.930
 Why?
Islets of Langerhans
5
2020
846
0.930
 Why?
Carcinoma, Neuroendocrine
2
2023
36
0.920
 Why?
Follow-Up Studies
24
2025
5423
0.920
 Why?
Venous Thrombosis
2
2025
196
0.920
 Why?
Endosonography
5
2021
160
0.900
 Why?
Biomarkers, Tumor
14
2026
1321
0.880
 Why?
Frozen Sections
1
2025
24
0.880
 Why?
Cystadenocarcinoma, Mucinous
3
2026
12
0.880
 Why?
Nomograms
3
2022
59
0.860
 Why?
Precancerous Conditions
3
2015
166
0.860
 Why?
Liver Neoplasms
4
2024
776
0.830
 Why?
Hepatoblastoma
1
2024
52
0.810
 Why?
Duodenal Neoplasms
3
2023
26
0.800
 Why?
Thrombelastography
2
2024
192
0.780
 Why?
Minimally Invasive Surgical Procedures
3
2020
189
0.720
 Why?
Fluorouracil
11
2025
231
0.710
 Why?
Leucovorin
8
2025
98
0.680
 Why?
Surgical Stapling
1
2021
15
0.670
 Why?
Absorbable Implants
1
2021
38
0.660
 Why?
Risk Assessment
11
2025
3747
0.650
 Why?
Incidence
11
2026
2923
0.650
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2022
229
0.650
 Why?
Organ Transplantation
2
2023
251
0.640
 Why?
Neoplasms, Second Primary
2
2019
102
0.640
 Why?
Sweden
6
2025
115
0.620
 Why?
Vascular Neoplasms
1
2020
18
0.620
 Why?
Neoplasms, Multiple Primary
3
2015
58
0.610
 Why?
Arteries
2
2019
261
0.610
 Why?
Risk Factors
21
2026
10885
0.610
 Why?
Liver Transplantation
4
2024
826
0.610
 Why?
Adenocarcinoma, Papillary
2
2017
11
0.600
 Why?
Pancreatitis
5
2022
146
0.600
 Why?
Deoxycytidine
9
2025
220
0.600
 Why?
Endocrine System Diseases
1
2019
35
0.590
 Why?
Practice Guidelines as Topic
4
2026
1581
0.590
 Why?
Neuroendocrine Tumors
4
2023
119
0.560
 Why?
Neoplasm Metastasis
2
2025
688
0.530
 Why?
Cohort Studies
12
2024
6013
0.520
 Why?
Evidence-Based Medicine
5
2024
740
0.520
 Why?
Europe
8
2021
418
0.510
 Why?
Patient Compliance
1
2021
587
0.510
 Why?
Living Donors
3
2016
282
0.500
 Why?
Metabolomics
2
2019
732
0.490
 Why?
Kidney Transplantation
17
2016
712
0.490
 Why?
Prospective Studies
17
2026
8057
0.490
 Why?
Hepatic Artery
4
2020
53
0.490
 Why?
Patient Selection
9
2024
738
0.480
 Why?
Celiac Artery
4
2020
20
0.480
 Why?
Hepatitis B virus
1
2016
33
0.470
 Why?
Pancreaticojejunostomy
3
2022
8
0.470
 Why?
Watchful Waiting
1
2016
90
0.470
 Why?
Disease Progression
6
2025
2864
0.460
 Why?
Hypothermia, Induced
1
2016
95
0.440
 Why?
Practice Patterns, Physicians'
4
2025
1371
0.440
 Why?
Organ Sparing Treatments
1
2015
37
0.430
 Why?
Pancreatic Diseases
3
2020
66
0.430
 Why?
Survival Analysis
12
2024
1374
0.420
 Why?
Postoperative Care
3
2026
286
0.420
 Why?
Laparoscopy
4
2025
481
0.420
 Why?
Adenoma
3
2025
218
0.420
 Why?
Antineoplastic Agents
6
2021
2214
0.400
 Why?
Radiotherapy, Adjuvant
2
2024
222
0.390
 Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2019
223
0.390
 Why?
Japan
5
2025
149
0.390
 Why?
Clinical Trials as Topic
1
2018
1061
0.390
 Why?
Cystadenocarcinoma
1
2013
4
0.390
 Why?
Cystadenoma
1
2013
5
0.390
 Why?
Combined Modality Therapy
5
2024
1266
0.390
 Why?
Robotics
1
2014
90
0.380
 Why?
Propensity Score
4
2026
377
0.370
 Why?
Italy
11
2013
116
0.360
 Why?
Cystadenoma, Serous
3
2020
18
0.360
 Why?
Carcinoma, Hepatocellular
1
2016
372
0.360
 Why?
Stomach Neoplasms
2
2024
128
0.360
 Why?
Diabetes Mellitus
3
2019
1097
0.360
 Why?
Autoimmune Diseases
3
2021
468
0.360
 Why?
Tomography, X-Ray Computed
10
2021
2769
0.350
 Why?
Diagnosis, Differential
8
2022
1508
0.350
 Why?
Dilatation, Pathologic
3
2020
61
0.340
 Why?
Peritoneal Neoplasms
2
2024
104
0.340
 Why?
Palliative Care
3
2019
1020
0.340
 Why?
Lymphatic Metastasis
4
2026
331
0.340
 Why?
Benchmarking
3
2026
191
0.340
 Why?
Cystadenoma, Mucinous
2
2026
11
0.330
 Why?
Predictive Value of Tests
7
2025
2121
0.330
 Why?
Risk
5
2022
919
0.330
 Why?
Gastroenterology
2
2023
191
0.320
 Why?
Gamma Rays
2
2021
57
0.320
 Why?
Adolescent
17
2026
22529
0.320
 Why?
Age Factors
7
2025
3342
0.310
 Why?
Microbiota
3
2025
730
0.310
 Why?
Portal System
6
2020
12
0.310
 Why?
Chemoradiotherapy
2
2022
239
0.310
 Why?
Neoplastic Syndromes, Hereditary
1
2010
47
0.310
 Why?
Young Adult
13
2026
14218
0.300
 Why?
Neoplasm Grading
4
2020
310
0.300
 Why?
Time Factors
11
2024
7123
0.300
 Why?
Magnetic Resonance Imaging
8
2021
3904
0.300
 Why?
Tissue Donors
14
2005
420
0.300
 Why?
Decision Making
1
2016
977
0.290
 Why?
Kidney
2
2016
1497
0.280
 Why?
Population Surveillance
2
2019
484
0.270
 Why?
Tumor Burden
2
2022
325
0.270
 Why?
Software
2
2017
680
0.260
 Why?
Graft Survival
12
2005
518
0.260
 Why?
Mass Screening
2
2019
1360
0.260
 Why?
Margins of Excision
2
2025
50
0.260
 Why?
Genetic Predisposition to Disease
6
2019
2378
0.250
 Why?
Internationality
4
2020
156
0.250
 Why?
Islets of Langerhans Transplantation
3
2020
70
0.250
 Why?
Family Health
1
2007
191
0.240
 Why?
Cytoreduction Surgical Procedures
2
2024
69
0.240
 Why?
Disease-Free Survival
5
2023
767
0.240
 Why?
Drainage
10
2022
185
0.240
 Why?
Pedigree
3
2014
515
0.240
 Why?
Intention to Treat Analysis
1
2026
79
0.240
 Why?
Lymphocytes, Tumor-Infiltrating
2
2018
153
0.240
 Why?
Multidetector Computed Tomography
2
2016
40
0.240
 Why?
Immunohistochemistry
5
2019
1716
0.230
 Why?
Observer Variation
2
2024
357
0.230
 Why?
Prevalence
4
2025
2865
0.230
 Why?
Pregnancy Complications, Neoplastic
1
2026
63
0.230
 Why?
Cyst Fluid
2
2022
20
0.230
 Why?
Netherlands
4
2026
84
0.220
 Why?
Pilot Projects
6
2026
1891
0.220
 Why?
Length of Stay
5
2021
1349
0.220
 Why?
Postoperative Hemorrhage
1
2026
105
0.220
 Why?
Diarrhea
1
2026
193
0.220
 Why?
Symptom Assessment
1
2026
136
0.220
 Why?
Cholangiocarcinoma
2
2024
108
0.220
 Why?
Mucosal-Associated Invariant T Cells
1
2025
38
0.210
 Why?
Pylorus
1
2024
17
0.210
 Why?
Proportional Hazards Models
4
2023
1327
0.210
 Why?
Chemoradiotherapy, Adjuvant
3
2019
44
0.210
 Why?
Gallbladder Neoplasms
1
2024
20
0.210
 Why?
Spheroids, Cellular
1
2025
74
0.210
 Why?
Cell Transformation, Neoplastic
1
2026
337
0.200
 Why?
Perioperative Care
2
2024
231
0.200
 Why?
Lymph Node Excision
1
2024
173
0.190
 Why?
Metastasectomy
1
2023
19
0.190
 Why?
Incidental Findings
2
2021
81
0.190
 Why?
Hyperemia
1
2023
49
0.190
 Why?
Child, Preschool
6
2026
11853
0.190
 Why?
Hospital Mortality
4
2020
1038
0.190
 Why?
Bile Duct Neoplasms
1
2024
131
0.190
 Why?
Surgical Oncology
1
2022
30
0.180
 Why?
Hyperamylasemia
1
2022
3
0.180
 Why?
Reoperation
7
2018
633
0.180
 Why?
STAT3 Transcription Factor
2
2022
206
0.180
 Why?
Sensitivity and Specificity
3
2026
1997
0.180
 Why?
Pancreatitis, Acute Necrotizing
1
2022
14
0.180
 Why?
Forecasting
1
2023
390
0.180
 Why?
Colonic Neoplasms
1
2024
257
0.180
 Why?
Carcinoma, Acinar Cell
1
2021
4
0.180
 Why?
Bacteria
2
2025
765
0.170
 Why?
Plastics
1
2022
50
0.170
 Why?
Pathology, Clinical
1
2021
29
0.170
 Why?
Biliary Tract Surgical Procedures
1
2021
28
0.170
 Why?
Angiotensin Receptor Antagonists
1
2022
115
0.170
 Why?
Datasets as Topic
1
2021
118
0.170
 Why?
Cysts
1
2022
112
0.170
 Why?
Multicenter Studies as Topic
1
2023
412
0.170
 Why?
ADAM10 Protein
1
2021
29
0.170
 Why?
Surgical Mesh
1
2021
50
0.160
 Why?
Fusobacterium nucleatum
1
2020
4
0.160
 Why?
Fusobacterium Infections
1
2020
7
0.160
 Why?
Amyloid Precursor Protein Secretases
1
2021
78
0.160
 Why?
Body Composition
1
2024
693
0.160
 Why?
United States
5
2025
16098
0.160
 Why?
Albumins
3
2025
119
0.160
 Why?
Surgeons
1
2025
340
0.160
 Why?
Microdissection
2
2011
13
0.160
 Why?
Digestive System Surgical Procedures
1
2021
112
0.160
 Why?
Oligonucleotides, Antisense
1
2020
118
0.160
 Why?
Blood
1
2020
107
0.160
 Why?
Quality Improvement
2
2026
1295
0.150
 Why?
Antimetabolites, Antineoplastic
2
2010
106
0.150
 Why?
Antibodies, Bacterial
1
2020
147
0.150
 Why?
Myeloid-Derived Suppressor Cells
1
2020
76
0.150
 Why?
Cyclosporine
4
2005
256
0.150
 Why?
Comorbidity
2
2022
1661
0.150
 Why?
Paclitaxel
3
2025
257
0.150
 Why?
Radiation Injuries
1
2021
149
0.150
 Why?
Conservative Treatment
1
2020
45
0.150
 Why?
Lasers
2
2011
126
0.150
 Why?
Dilatation
1
2019
71
0.150
 Why?
Cystadenocarcinoma, Serous
1
2020
89
0.150
 Why?
Biliary Tract Diseases
1
2019
33
0.140
 Why?
Epithelial-Mesenchymal Transition
1
2021
219
0.140
 Why?
Bacterial Infections
1
2021
246
0.140
 Why?
Laparotomy
2
2016
113
0.140
 Why?
Bile Ducts
1
2019
68
0.140
 Why?
Elective Surgical Procedures
1
2020
202
0.140
 Why?
Organ Culture Techniques
1
2019
154
0.140
 Why?
Mouth
1
2019
86
0.140
 Why?
Immunosuppressive Agents
6
2005
838
0.140
 Why?
Saliva
1
2020
246
0.140
 Why?
Nutritional Support
1
2018
39
0.140
 Why?
Gene Expression Regulation, Neoplastic
4
2019
1443
0.140
 Why?
Fibrosis
1
2021
559
0.140
 Why?
Iopamidol
2
2016
12
0.140
 Why?
Recombinant Fusion Proteins
4
2005
666
0.130
 Why?
Patient Care Team
3
2020
696
0.130
 Why?
Carcinoma
1
2019
225
0.130
 Why?
DNA Damage
1
2021
437
0.130
 Why?
Jejunum
2
2016
37
0.130
 Why?
Referral and Consultation
1
2024
867
0.130
 Why?
Insulin
8
2013
2512
0.130
 Why?
Preoperative Care
2
2026
380
0.130
 Why?
Societies, Medical
2
2020
899
0.130
 Why?
DNA, Bacterial
1
2019
320
0.130
 Why?
Logistic Models
2
2020
2134
0.130
 Why?
Kaplan-Meier Estimate
2
2016
969
0.130
 Why?
Surveys and Questionnaires
5
2025
6066
0.130
 Why?
Patient Acceptance of Health Care
1
2024
881
0.130
 Why?
Malnutrition
1
2018
86
0.130
 Why?
Analgesics, Opioid
1
2025
1149
0.120
 Why?
Radiosurgery
1
2020
399
0.120
 Why?
Hepatic Duct, Common
1
2016
5
0.120
 Why?
Jaundice, Obstructive
1
2016
3
0.120
 Why?
Biliary Tract Neoplasms
1
2016
31
0.120
 Why?
Epitopes
1
2018
473
0.120
 Why?
Cross-Sectional Studies
3
2024
5904
0.120
 Why?
Cholangiopancreatography, Magnetic Resonance
1
2016
24
0.120
 Why?
Triiodobenzoic Acids
1
2016
6
0.120
 Why?
Organ Preservation Solutions
3
2005
46
0.120
 Why?
Cholangitis, Sclerosing
1
2016
61
0.120
 Why?
Hyperglycemia
1
2020
379
0.120
 Why?
Radiographic Image Enhancement
1
2016
57
0.120
 Why?
Sex Factors
1
2022
2105
0.110
 Why?
Cannabis
1
2023
509
0.110
 Why?
Embolization, Therapeutic
1
2018
242
0.110
 Why?
Bacteriocins
1
2015
5
0.110
 Why?
Hepatitis B
1
2016
66
0.110
 Why?
Genes, BRCA2
1
2015
33
0.110
 Why?
Printing, Three-Dimensional
1
2016
101
0.110
 Why?
Genes, BRCA1
1
2015
45
0.110
 Why?
Interferon-gamma
1
2018
784
0.110
 Why?
Pneumonia, Viral
1
2020
389
0.110
 Why?
Recovery of Function
1
2019
716
0.110
 Why?
Coronavirus Infections
1
2020
383
0.110
 Why?
Papilloma, Intraductal
1
2014
1
0.110
 Why?
Heredity
1
2014
13
0.110
 Why?
Machine Learning
1
2020
587
0.110
 Why?
Organ Preservation
3
2004
125
0.110
 Why?
Diabetes Mellitus, Type 1
10
2010
3922
0.110
 Why?
Membrane Proteins
1
2021
1164
0.100
 Why?
Apoptosis
6
2021
2440
0.100
 Why?
Genomics
2
2017
825
0.100
 Why?
Germany
2
2024
138
0.100
 Why?
Risk Adjustment
1
2014
85
0.100
 Why?
Amylases
1
2013
18
0.100
 Why?
High-Throughput Nucleotide Sequencing
1
2017
530
0.100
 Why?
Neoplasm, Residual
1
2014
143
0.100
 Why?
Tissue and Organ Harvesting
5
2005
78
0.100
 Why?
MicroRNAs
2
2010
686
0.100
 Why?
Virus Diseases
1
2016
216
0.100
 Why?
Health Care Surveys
2
2025
536
0.100
 Why?
Reproducibility of Results
6
2019
3413
0.100
 Why?
North America
2
2024
302
0.100
 Why?
Tacrolimus
2
2005
196
0.100
 Why?
Severity of Illness Index
3
2019
2930
0.100
 Why?
Cell Proliferation
5
2021
2507
0.100
 Why?
Perception
1
2016
378
0.100
 Why?
Antibodies, Monoclonal
4
2005
1505
0.100
 Why?
Syndrome
1
2014
381
0.100
 Why?
Abdomen
2
2004
142
0.100
 Why?
Precision Medicine
1
2017
459
0.090
 Why?
Cadaver
8
2005
311
0.090
 Why?
Breast Neoplasms
2
2024
2382
0.090
 Why?
Diagnostic Imaging
1
2015
337
0.090
 Why?
Imaging, Three-Dimensional
1
2016
583
0.090
 Why?
Diagnostic Errors
1
2014
178
0.090
 Why?
Insulin-Secreting Cells
2
2007
392
0.090
 Why?
ROC Curve
3
2024
617
0.090
 Why?
Immunotherapy, Adoptive
1
2016
342
0.090
 Why?
Receptors, Antigen, T-Cell
1
2016
673
0.090
 Why?
Endoscopy
1
2014
317
0.090
 Why?
Child
6
2026
22707
0.090
 Why?
Catheter Ablation
1
2015
355
0.090
 Why?
C-Reactive Protein
1
2013
422
0.080
 Why?
Neoplasms
2
2022
2906
0.080
 Why?
Loss of Heterozygosity
1
2011
52
0.080
 Why?
Carcinoma in Situ
1
2011
44
0.080
 Why?
Graft Rejection
5
2005
521
0.080
 Why?
Biomarkers
1
2022
4295
0.080
 Why?
Kruppel-Like Transcription Factors
1
2011
82
0.080
 Why?
Raffinose
3
2005
29
0.080
 Why?
Disaccharides
3
2005
21
0.080
 Why?
Mannitol
3
2005
40
0.080
 Why?
Glucose
3
2020
1048
0.080
 Why?
Allopurinol
3
2005
70
0.080
 Why?
Histidine
3
2005
66
0.080
 Why?
Glutamates
3
2005
66
0.080
 Why?
Electrolytes
3
2005
54
0.080
 Why?
Tissue and Organ Procurement
2
2004
343
0.080
 Why?
Lung Neoplasms
1
2023
2664
0.080
 Why?
CD8-Positive T-Lymphocytes
1
2016
919
0.070
 Why?
Duodenum
1
2010
77
0.070
 Why?
Quality of Health Care
1
2014
692
0.070
 Why?
Lymph Nodes
2
2024
503
0.070
 Why?
Peptides
1
2015
998
0.070
 Why?
Tumor Cells, Cultured
2
2021
886
0.070
 Why?
Cell Line, Tumor
4
2025
3542
0.070
 Why?
Down-Regulation
1
2011
618
0.070
 Why?
Intra-Abdominal Fat
1
2009
101
0.070
 Why?
Adenosine
3
2005
255
0.070
 Why?
Glutathione
3
2005
370
0.070
 Why?
Magnetic Resonance Angiography
1
2010
251
0.070
 Why?
T-Lymphocytes, Regulatory
2
2022
409
0.070
 Why?
Enzyme Replacement Therapy
2
2018
15
0.070
 Why?
Feasibility Studies
2
2026
1111
0.070
 Why?
Germ-Line Mutation
2
2019
176
0.070
 Why?
Morbidity
2
2019
322
0.060
 Why?
ErbB Receptors
1
2010
635
0.060
 Why?
Gliclazide
1
2007
2
0.060
 Why?
Consensus
2
2020
477
0.060
 Why?
Diabetic Retinopathy
2
2006
209
0.060
 Why?
Cytotoxicity, Immunologic
2
2018
224
0.060
 Why?
Equilibrative Nucleoside Transporter 1
1
2006
19
0.060
 Why?
Arterial Occlusive Diseases
1
2007
90
0.060
 Why?
Extracorporeal Circulation
1
2006
14
0.060
 Why?
Clinical Decision-Making
2
2020
363
0.060
 Why?
Blood Loss, Surgical
1
2007
113
0.060
 Why?
Pancreatic Pseudocyst
1
2025
18
0.060
 Why?
Hepatic Veins
1
2006
32
0.060
 Why?
C-Peptide
1
2007
190
0.060
 Why?
Lacerations
1
2006
40
0.060
 Why?
Hepatectomy
2
2024
274
0.060
 Why?
Neovascularization, Pathologic
1
2007
286
0.060
 Why?
Tumor Microenvironment
2
2020
734
0.060
 Why?
Vena Cava, Inferior
1
2006
83
0.060
 Why?
Smartphone
1
2026
106
0.050
 Why?
Smoking
2
2013
1472
0.050
 Why?
Alcohol Drinking
2
2013
837
0.050
 Why?
Transplantation, Autologous
1
2006
300
0.050
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2024
30
0.050
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2007
239
0.050
 Why?
Drug Resistance, Neoplasm
1
2010
881
0.050
 Why?
Abdominal Injuries
1
2006
130
0.050
 Why?
Jehovah's Witnesses
1
2004
3
0.050
 Why?
Bezoars
1
2004
5
0.050
 Why?
Succinimides
1
2024
21
0.050
 Why?
Biopsy
3
2019
1082
0.050
 Why?
Anthropometry
1
2024
206
0.050
 Why?
Contrast Media
3
2016
497
0.050
 Why?
Splenectomy
1
2024
61
0.050
 Why?
Chemotaxis
1
2004
122
0.050
 Why?
Intestinal Obstruction
1
2004
55
0.050
 Why?
Cystectomy
1
2003
42
0.050
 Why?
RNA, Messenger
5
2011
2803
0.050
 Why?
Mobile Applications
1
2026
199
0.050
 Why?
Antioxidants
1
2007
550
0.050
 Why?
Intestine, Small
1
2004
167
0.050
 Why?
Postoperative Period
2
2019
351
0.050
 Why?
Ileum
1
2003
112
0.050
 Why?
Intraoperative Complications
1
2004
157
0.050
 Why?
Wounds, Nonpenetrating
1
2006
321
0.050
 Why?
Academic Medical Centers
1
2025
554
0.050
 Why?
Propylamines
1
2022
11
0.050
 Why?
Delphi Technique
1
2024
332
0.040
 Why?
Carbohydrates
1
2022
66
0.040
 Why?
Genetic Testing
1
2005
480
0.040
 Why?
Program Evaluation
1
2026
943
0.040
 Why?
Patient Satisfaction
1
2026
709
0.040
 Why?
Azathioprine
1
2001
44
0.040
 Why?
Patient Reported Outcome Measures
1
2026
497
0.040
 Why?
Stents
2
2022
564
0.040
 Why?
Gastrectomy
1
2023
166
0.040
 Why?
Creatinine
4
2004
515
0.040
 Why?
Urinary Bladder
1
2003
195
0.040
 Why?
Vascular Diseases
1
2004
252
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
977
0.040
 Why?
Guideline Adherence
1
2025
586
0.040
 Why?
Mycophenolic Acid
1
2001
120
0.040
 Why?
Necrosis
1
2022
244
0.040
 Why?
Retroperitoneal Space
3
2005
18
0.040
 Why?
Ephrin-B2
1
2021
45
0.040
 Why?
Steroids
1
2001
160
0.040
 Why?
Hernia, Inguinal
1
2001
43
0.040
 Why?
Endometriosis
1
2001
58
0.040
 Why?
Hyperplasia
1
2021
177
0.040
 Why?
Endoscopy, Gastrointestinal
1
2023
237
0.040
 Why?
Urinary Bladder Neoplasms
1
2003
258
0.040
 Why?
Microbial Viability
1
2021
83
0.040
 Why?
Case-Control Studies
2
2022
3623
0.040
 Why?
Diagnosis, Computer-Assisted
1
2020
92
0.040
 Why?
Capecitabine
1
2019
56
0.040
 Why?
Adipose Tissue
1
2024
645
0.040
 Why?
Secretin
2
2010
6
0.040
 Why?
Matched-Pair Analysis
1
2019
37
0.040
 Why?
Republic of Korea
1
2019
43
0.040
 Why?
Florida
1
2020
117
0.040
 Why?
Medical Oncology
1
2022
339
0.040
 Why?
Mice, Inbred C57BL
2
2021
5983
0.040
 Why?
Asia
1
2019
70
0.040
 Why?
Treatment Failure
3
2005
360
0.040
 Why?
Mice
3
2022
18329
0.040
 Why?
International Cooperation
1
2020
197
0.040
 Why?
Patient Discharge
1
2026
992
0.040
 Why?
Hematopoietic Stem Cell Transplantation
1
2005
699
0.040
 Why?
Cell Death
1
2021
382
0.040
 Why?
Cells, Cultured
3
2016
4148
0.040
 Why?
Hyperthermia, Induced
1
2020
120
0.040
 Why?
Area Under Curve
1
2019
331
0.040
 Why?
Aquaporin 1
1
2018
3
0.040
 Why?
Acute Disease
1
2022
1036
0.040
 Why?
Mice, Nude
1
2020
679
0.040
 Why?
Radiotherapy
1
2019
204
0.040
 Why?
Pancreatic Elastase
1
2018
53
0.030
 Why?
Stromal Cells
1
2019
121
0.030
 Why?
Congresses as Topic
1
2020
223
0.030
 Why?
Cause of Death
3
2005
470
0.030
 Why?
Anastomosis, Roux-en-Y
2
2010
26
0.030
 Why?
Multivariate Analysis
2
2013
1547
0.030
 Why?
Hospitals, High-Volume
1
2018
50
0.030
 Why?
Xenograft Model Antitumor Assays
1
2021
934
0.030
 Why?
Preoperative Period
1
2018
149
0.030
 Why?
Tumor Suppressor Protein p53
2
2017
534
0.030
 Why?
Betacoronavirus
1
2020
288
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2010
749
0.030
 Why?
Intestinal Neoplasms
1
2016
30
0.030
 Why?
Patient Safety
1
2020
356
0.030
 Why?
Registries
1
2025
2406
0.030
 Why?
Diabetic Nephropathies
3
2005
322
0.030
 Why?
Cell Movement
1
2021
959
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2017
254
0.030
 Why?
Drug Therapy, Combination
3
2004
1044
0.030
 Why?
Mass Spectrometry
1
2019
730
0.030
 Why?
Principal Component Analysis
1
2016
193
0.030
 Why?
Robotic Surgical Procedures
1
2019
185
0.030
 Why?
Transplantation, Homologous
2
2010
418
0.030
 Why?
Nutritional Status
1
2018
353
0.030
 Why?
Anastomosis, Surgical
1
2016
162
0.030
 Why?
Vitamins
1
2017
182
0.030
 Why?
Research Design
1
2021
1137
0.030
 Why?
Cell Line
1
2021
2823
0.030
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
122
0.030
 Why?
Feces
1
2018
495
0.030
 Why?
Anatomy, Cross-Sectional
1
2014
11
0.030
 Why?
Flow Cytometry
1
2018
1162
0.030
 Why?
Extracellular Matrix
1
2019
562
0.030
 Why?
Radiation Dosage
1
2016
193
0.030
 Why?
Animals
3
2022
38030
0.030
 Why?
Intraoperative Care
1
2014
63
0.030
 Why?
Antigens, Neoplasm
1
2016
271
0.030
 Why?
Systemic Inflammatory Response Syndrome
1
2014
95
0.030
 Why?
Kidney Failure, Chronic
3
2004
599
0.030
 Why?
Immunologic Memory
1
2016
368
0.020
 Why?
Dose-Response Relationship, Drug
2
2010
2028
0.020
 Why?
Indole Alkaloids
1
2013
7
0.020
 Why?
Drug Administration Schedule
2
2005
782
0.020
 Why?
Cytokines
2
2016
2067
0.020
 Why?
Drug Interactions
2
2005
405
0.020
 Why?
Peptic Ulcer
1
2013
18
0.020
 Why?
Biomedical Research
1
2019
717
0.020
 Why?
Pregnancy
1
2026
7202
0.020
 Why?
Histocompatibility Testing
2
2004
123
0.020
 Why?
Algorithms
1
2020
1845
0.020
 Why?
Asymptomatic Diseases
1
2013
104
0.020
 Why?
Safety
2
2004
358
0.020
 Why?
Lymphocyte Activation
1
2016
1132
0.020
 Why?
Global Health
1
2015
403
0.020
 Why?
Pandemics
1
2020
1707
0.020
 Why?
Hypoxia
1
2019
1199
0.020
 Why?
Infant
1
2025
10077
0.020
 Why?
Carcinoma, Renal Cell
1
2013
230
0.020
 Why?
In Situ Hybridization
1
2011
318
0.020
 Why?
Korea
1
2010
18
0.020
 Why?
Cell Growth Processes
1
2010
48
0.020
 Why?
Randomized Controlled Trials as Topic
1
2017
1747
0.020
 Why?
Matrix Metalloproteinase 2
1
2010
56
0.020
 Why?
Microsatellite Repeats
1
2011
157
0.020
 Why?
Odds Ratio
1
2013
1082
0.020
 Why?
Biopsy, Needle
1
2010
185
0.020
 Why?
Lung
1
2023
4106
0.020
 Why?
Anti-Bacterial Agents
1
2021
1923
0.020
 Why?
Matrix Metalloproteinase 9
1
2010
131
0.020
 Why?
Pyridoxal Phosphate
1
2009
20
0.020
 Why?
Cardiovascular Diseases
1
2001
2187
0.020
 Why?
Edetic Acid
1
2009
47
0.020
 Why?
Thyroid Neoplasms
1
2013
350
0.020
 Why?
PTEN Phosphohydrolase
1
2010
165
0.020
 Why?
Blood Glucose
3
2004
2341
0.020
 Why?
Kidney Neoplasms
1
2013
413
0.020
 Why?
Tetrazolium Salts
1
2008
18
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2010
440
0.020
 Why?
Thiazoles
1
2008
141
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2010
552
0.020
 Why?
Glyburide
1
2007
31
0.020
 Why?
bcl-2-Associated X Protein
1
2007
53
0.020
 Why?
Surgical Procedures, Operative
1
2010
271
0.020
 Why?
Recurrence
1
2010
1138
0.020
 Why?
Epigenesis, Genetic
1
2011
679
0.020
 Why?
Deoxycytidine Kinase
1
2006
3
0.020
 Why?
Microscopy, Electron
1
2007
414
0.020
 Why?
Ribonucleoside Diphosphate Reductase
1
2006
6
0.020
 Why?
Tyrosine
1
2007
217
0.010
 Why?
Choledochostomy
1
2006
10
0.010
 Why?
Motorcycles
1
2006
7
0.010
 Why?
Budd-Chiari Syndrome
1
2006
5
0.010
 Why?
Mutation
1
2017
4075
0.010
 Why?
5'-Nucleotidase
1
2006
49
0.010
 Why?
Cytidine Deaminase
1
2006
59
0.010
 Why?
Prostatic Neoplasms
1
2013
978
0.010
 Why?
Phosphorylation
1
2010
1707
0.010
 Why?
Economics, Pharmaceutical
1
2005
10
0.010
 Why?
Antilymphocyte Serum
1
2005
57
0.010
 Why?
Fluorescein Angiography
1
2006
190
0.010
 Why?
Methylprednisolone
1
2005
59
0.010
 Why?
Fatal Outcome
1
2006
305
0.010
 Why?
Blood Group Incompatibility
1
2005
21
0.010
 Why?
Maximum Tolerated Dose
1
2005
210
0.010
 Why?
Colorectal Neoplasms
1
2013
866
0.010
 Why?
Isoantibodies
1
2005
57
0.010
 Why?
Glycerolphosphate Dehydrogenase
1
2004
5
0.010
 Why?
Proteomics
1
2011
1188
0.010
 Why?
Accidents, Traffic
1
2006
193
0.010
 Why?
Fructose-Bisphosphate Aldolase
1
2004
10
0.010
 Why?
Hemorrhage
1
2010
822
0.010
 Why?
Glucokinase
1
2004
15
0.010
 Why?
DNA Primers
1
2005
505
0.010
 Why?
Intraocular Pressure
1
2006
329
0.010
 Why?
Pyruvate Kinase
1
2004
28
0.010
 Why?
Tissue Culture Techniques
1
2004
82
0.010
 Why?
Transcriptional Activation
1
2006
372
0.010
 Why?
Pharmacogenetics
1
2005
175
0.010
 Why?
Diabetic Neuropathies
1
2005
100
0.010
 Why?
Renal Circulation
1
2004
75
0.010
 Why?
Tumor Suppressor Proteins
1
2006
321
0.010
 Why?
Visual Acuity
1
2006
491
0.010
 Why?
Kidney Function Tests
1
2003
156
0.010
 Why?
Carcinoma, Transitional Cell
1
2003
68
0.010
 Why?
Monitoring, Physiologic
1
2005
288
0.010
 Why?
Cell Separation
1
2004
305
0.010
 Why?
In Vitro Techniques
1
2004
1048
0.010
 Why?
Respiratory Insufficiency
1
2006
326
0.010
 Why?
Base Sequence
1
2005
2170
0.010
 Why?
Vulvar Diseases
1
2001
9
0.010
 Why?
Thrombosis
1
2005
400
0.010
 Why?
Immunoenzyme Techniques
1
2001
200
0.010
 Why?
Obesity, Morbid
1
2005
293
0.010
 Why?
Gene Expression
1
2006
1476
0.010
 Why?
Glucocorticoids
1
2005
531
0.010
 Why?
Ischemia
1
2004
422
0.010
 Why?
Morphogenesis
1
2001
172
0.010
 Why?
Hemodynamics
1
2004
1118
0.010
 Why?
Neoplasm Proteins
1
2001
441
0.010
 Why?
Blood Pressure
1
2005
1779
0.010
 Why?
T-Lymphocytes
1
2005
1996
0.010
 Why?
Body Mass Index
1
2004
2445
0.010
 Why?
Hypoglycemic Agents
1
2005
1399
0.010
 Why?
Infant, Newborn
1
2001
6447
0.000
 Why?
Del Chiaro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (599) concept(s)
_
Co-Authors Expand Description
See all (60) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)